Fate to be decided over the next year

Dr Fraser Mustard and a group of influential colleagues are preparing to tackle one the most vexing dilemmas facing Canadian health research. With the recent creation of the not-for-profit Canadian Biotechnology Commercialization Initiative (CBCI), its backers hope to avoid the so-called valley of death that has stalled or diluted the commercial potential of promising research as it moves from the lab bench to the marketplace.